Evidence map›Paper›PMID 30301735›Full record

SynthesisBritish journal of sports medicine2019

Topical glyceryl trinitrate for the treatment of tendinopathies: a systematic review.

Dimitris Challoumas, Paul D Kirwan, Dmytro Borysov, Christopher Clifford, Michael McLean, Neal L Millar

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in British journal of sports medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 5 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 5 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Can Topical Glyceryl Trinitrate be Effective in the Treatment of Levator Ani Syndrome?The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Dutch multidisciplinary guideline on Achilles tendinopathy.British journal of sports medicine · 2021
    Article
  14. Platelet-rich plasma injections.Canadian family physician Medecin de famille canadien · 2020
    Article
  15. Recent advances in tendinopathy.Faculty reviews · 2020
    Review
  16. 15-Epi-LXAFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Dimitris ChalloumasInstitute of Infection, Immunity and Inflammation, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Paul D KirwanSchool of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland.
Dmytro BorysovInstitute of Infection, Immunity and Inflammation, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Christopher CliffordPhysiotherapy Department, West Glasgow Acute Care Hospital, Glasgow, UK.
Michael McLeanInstitute of Infection, Immunity and Inflammation, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Neal L MillarInstitute of Infection, Immunity and Inflammation, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0001-9251-9907
Institute of Infection and Immunity · CAPhysiotherapy New Zealand · NZRoyal College of Surgeons in Ireland · IE

Funding

Medical Research Council MR/R020515/1Versus Arthritis 21346
6 · The paper itself

Abstract

objectiveTo produce a best evidence synthesis of the clinical effects of topical glyceryl trinitrate (GTN) in the treatment of tendinopathies.

designA systematic review of published randomised controlled trials (RCTs) of the use of GTN in patients with tendinopathy. DATA SOURCES: MEDLINE, Embase, Scopus and CINAHL from database inception to January 2018.

methodsWe examined RCTs comparing the effects of topical GTN with either placebo or other treatments on tendinopathy. Overall quality of each eligible study was determined based on a combined assessment of internal validity, external validity and precision. The level of evidence for each assessed parameter was rated based on the system by van Tulder

resultsA total of 10 eligible RCTs were identified including patients with tendinopathy of the rotator cuff (n=4), wrist extensors (n=3), Achilles (n=2) and patellar (n=1) tendons. For all tendinopathies, improvements in pain were significant when comparing GTN versus placebo in the short term (<8 weeks; poor evidence). Significant improvements in midterm outcomes for treatment with GTN versus placebo included the following: patient satisfaction (strong evidence); chances of being asymptomatic with activities of daily living (strong evidence); range of movement (moderate evidence); strength (moderate evidence); pain (at night and with activity; poor evidence) and local tenderness (poor evidence). Patients treated with topical GTN reported a higher incidence of headaches than those who received placebo (moderate evidence). CONCLUSIONS AND RELEVANCE: Treatment of tendinopathies with topical GTN for up to 6 months appears to be superior to placebo and may therefore be a useful adjunct to the treating healthcare professions.

Indexed as

Achilles TendonActivities of Daily LivingAdministration, CutaneousCumulative Trauma DisordersHumansNitroglycerinPainPatient SatisfactionRandomized Controlled Trials as TopicRotator CuffTendinopathyNitroglycerinoveruse injurytendinopathytendinosistendontreatment

Identifiers

PMID30301735
PMCPMC6362607
OpenAlexW2897618771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.